Flinders Lab Shows Vanillin Acts as Dynamic Crosslinker With Antioxidant, Anti-Inflammatory and Antibacterial Activity for Chronic Wound Matrices

The team screened vanillin in hydrogel and nanofiber formulations using in-vitro models of oxidative stress, LPS-stimulated macrophages and S. aureus biofilms. Vanillin reduced ROS levels by 60-75 percent, lowered TNF-α and IL-6 secretion, and achieved >3-log bacterial reduction at concentrations compatible with human fibroblasts. These effects were attributed to its aldehyde and phenolic moieties acting as both radical scavengers and dynamic Schiff-base crosslinkers within the polymer network. The work extends the lab's February 2026 peppermint-oil coating study, which similarly exploited food-grade terpenes for anti-biofilm surfaces, indicating a deliberate pivot toward generally-recognized-as-safe molecules that bypass lengthy toxicology packages. Regulatory precedent for vanillin as a food additive could shorten the path to 510(k) or CE-mark clearance compared with novel synthetics. Remaining gaps include absence of in-vivo diabetic-wound data and no head-to-head comparison against silver or honey-based commercial products.